Uluwehi O "Reduxine": hōʻike manaʻo a me ka Customer manaʻo

Overweight kanaka, ua pinepine loa eiiieaena e pili ana i ka mea a me ka huli ana no me ka dukima aoao, e lilo ke kaupaona: no ka mea simplest o kaʻai hoʻi, a dietary kapu i kūikawā o na papa io. He 'atikala e olelo pono ma kahi o kekahi e like me ka lapaʻauʻia - ka lāʻau "Reduxine". Comments nā kānaka kūʻai mai hōʻike 'ana i ka mea loaʻa he like ia me ka lāʻau "Meridia", hoomaopopo ana i ke kino a me ka enterosorbiruyuschee anorectics keiki.

modalities

I ka papa kuhikuhiEʻeleu 'Oponopono o pharmaceuticals "Reduxine" - sibutramine, a hoakaka i ka blockade o ka reuptake o norepinephrine a me ka serotonin. Ma lalo o ka hana o ka sibutramine maʻiʻo, piʻi pū neurotransmitters ma synapses, piʻi pū, a adrenergic aayoaeuiinoe, a kikowaena serotonin receptors, i kumu no ke kanaka i ka manao o ka satiety, ho'ēmi i kā i ka nele i ka ai, a maoli he ka helu termoproduktsii. Keia mea ua hookupaa iho la ia e na mea he nui kanaka e waiho ana i ka lāʻau "Reduxine 'hōʻike manaʻo a me nā manaʻo.

Eia hou kekahi, sibutramine e loli aiʻeleʻele adipose'aʻaʻa, ho'ā 'ia paha i ka b3-adrenergic receptors. Ma ka hoemi kino kaumaha ma ka lāʻau lapaʻau ana e hoʻoulu ai i ka lehulehu o HDL, a ua hoʻemi i ka nui o ka huina naʻokoko, uricʻakika, triglycerides a me LDL.

Kekahi integral ke keʻena "Reduxine" medicament ka microcrystalline kelulose e lawelawe me enterosorbent. Ka mea, i ke kanawai o ke detoxication a me ka sorption ka waiwai, a me ka pōpilikia 'ana i ke kūlana o ka paa ana o kekahi mau microorganisms, kā lākou metabolic huahana, xenobiotics, toxins endogenous a me exogenous ano, allergens, e like me kekahi oi metabolites a me metabolic huahana i kuleana no keʻano o ka endogenous toxicosis.

Nāʻikepili no ka hoʻohana

Pono he mau nāʻikepili ma o ka noi wehewehe pili ana i ka lāʻau "Reduxine" ke aʻoʻia. O nā mea kūʻai mai nei no hoi ia ia i ka medicament no ka iapaau ana o alimentary obesity ma ka 'inideka o 30 kg / m2 kino paona a oi. Inā ua nui na kamepiula kumumea like me hihia hoʻi lipid pūnao (dislipoproteinemia) ai 'ano 2 mimikō, e hiki ke lawe i kēia ka lapaʻauʻia me ke kino nuipa inideka 27 kg / m2.

Contraindications

Kekahi kanaka i makemake e lilo ke kaupaonaʻana ka hoʻohana 'ana i ka lāʻau "Reduxine' hōʻike manaʻo a me nā manaʻo i koe ma ka mea e hoʻolauna 'ē nā mea kūʻai mai me contraindications. Mawaena o lakou, i helu: pā lonoaʻili i hoʻopā ai o ka lapaʻauʻia eiiiiiaiou, noʻonoʻo, nā kīnānā, ke aloha kumu o ka obesity (e laʻa me, hypothyroidism), nui ai kāna hana (bulimia nervosa a anorexia), i ka wā hoʻokahi pharmaceuticals ka heluna o ka CNS, huina-panina glaucoma, thyrotoxicosis.

ʻaoʻao waiwai

I kekahi manawa 'oe ke' ike i ka makaukau ana o ka "Reduxine" io manaʻo. Loa pinepine ka mea, e pili me kaʻaoʻao 'ole o ka mea lāʻau lapaʻau. I waena o ia mau loa pinepine ana: constipation, maloo waha, Kanikani'āʻula, poho o kona'ōpū. More kākaʻikahi malama: palpitations, tachycardia, ua hoʻokiʻekiʻeʻia ke koko, headaches, uunu nui, pōniuniu, loli ma ka ho'āʻoʻana, a me ka sweating nausea. Loa kākaʻikahi hoikeia clinically nui adverse 'ole, e like me maʻi palū-me maʻi pale, dysmenorrhea, ili ka ohane ame, kaʻeha ma ka hope a me abdomen, edema, rhinitis, ka makewai, kaumaha, uunu nui, drowsiness, nervousness, irritability, convulsions, a e kahe ana ke koko.

Uluwehi O "Reduxine" a me ka hāpai keiki

Wahine ka mea kākau e pili ana i lapaau "Reduxine 'hōʻike manaʻo a me ka manaʻo, e hoailona oukou ia ia,ʻaʻole e hiki ke hoʻohana' ina o ka wahine e breastfeeding i ke keiki a me ka hapai.